A Study to Evaluate TOUR006 in Patients With Chronic Kidney Disease and Elevated Hs-CRP

PHASE2Active, not recruitingINTERVENTIONAL
Enrollment

143

Participants

Timeline

Start Date

May 15, 2024

Primary Completion Date

March 6, 2025

Study Completion Date

December 31, 2025

Conditions
Chronic Kidney DiseasesChronic Kidney InsufficiencyChronic Renal DiseasesChronic Renal InsufficiencyKidney Insufficiency, ChronicC-Reactive ProteinHigh Sensitivity C-Reactive ProteinHs-CRPhsCRP
Interventions
DRUG

TOUR006 - 50 MG

TOUR006 50 MG

DRUG

TOUR006 - 25 MG

TOUR006 25 MG

DRUG

TOUR006 - 15 MG

TOUR006 15 MG

OTHER

Placebo

Placebo

Trial Locations (42)

10940

Site - 0130, Middletown

18017

Site - 0132, Bethlehem

20110

Site - 0109, Manassas

26505

Site - 0147, Morgantown

26537

Site - 0137, Kingwood

28208

Site - 0110, Charlotte

29607

Site - 0103, Greenville

29707

Site - 0102, Fort Mill

29732

Site - 0118, Rock Hill

31406

Site - 0122, Savannah

32127

Site - 0119, Port Orange

33024

Site - 0149, Pembroke Pines

33317

Site - 0144, Plantation

33434

Site - 0142, Boca Raton

33634

Site - 0151, Tampa

35209

Site - 0101, Birmingham

35763

Site - 0135, Huntsville

35805

Site - 0145, Huntsville

37923

Site - 0108, Knoxville

43302

Site - 0127, Marion

45219

Site - 0120, Cincinnati

48081

Site - 0140, Saint Clair Shores

51501

Site - 0114, Council Bluffs

53144

Site - 0134, Kenosha

58104

Site - 0117, Fargo

60655

Site - 0106, Chicago

61550

Site - 0115, Morton

70006

Site - 0129, Metairie

75069

Site - 0150, McKinney

75402

Site - 0148, Greenville

76550

Site - 0111, Lampasas

77043

Site - 0105, Houston

78212

Site - 0107, San Antonio

78255

Site - 0141, San Antonio

85018

Site - 0104, Phoenix

89121

Site - 0123, Las Vegas

91355

Site - 0112, Valencia

Site - 0128, Valencia

91773

Site - 0125, San Dimas

334667

Site - 0113, Greenacres City

06905

Site - 0136, Stamford

02818

Site - 0126, Providence

All Listed Sponsors
lead

Tourmaline Bio, Inc.

INDUSTRY

NCT06362759 - A Study to Evaluate TOUR006 in Patients With Chronic Kidney Disease and Elevated Hs-CRP | Biotech Hunter | Biotech Hunter